Dehydroevodiamine Alleviates Doxorubicin-Induced Cardiomyocyte Injury by Regulating Neuregulin-1/ErbB Signaling

Dehydroevodiamine Alleviates Doxorubicin-Induced Cardiomyocyte Injury by Regulating Neuregulin-1/ErbB Signaling

Conclusion: DHE protects cardiomyocytes against DOX by regulating NRG1/ErbB pathway. DHE may be a potential agent for the prevention and treatment of DIC.

Saved in:

Bibliographic Details
Main Authors:	Song Jie, Guo Wenying, Sun Lebo
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Cardiovascular Therapeutics
Online Access:	http://dx.doi.org/10.1155/cdr/5538740
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

L-Arginine Activates the Neuregulin-1/ErbB Receptor Signaling Pathway and Increases Utrophin mRNA Levels in C2C12 Cells
by: Gladys Tapia, et al.
Published: (2025-01-01)

Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
by: Marc R Birtwistle, et al.
Published: (2007-11-01)

Prefrontal ErbB4-positive interneurons for avoidance
by: Wanpeng Cui, et al.
Published: (2025-05-01)

Clinicopathological value of ErbB2 gene and protein expression in osteochondroma
by: Zhen Huang, et al.
Published: (2020-01-01)

Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
by: Gillian Farnie, et al.
Published: (2013-01-01)

Exploring the Effects of Acupuncture on Behaviors of Autism Spectrum Disorder Based on the NRG1/ErbB4 Signaling Pathway
by: ZHUANG Wanyu, et al.
Published: (2025-02-01)

Vitamin D ameliorates prediabetic cardiac injure via modulation of the ErbB4/ferroptosis signaling axis
by: Yufan Miao, et al.
Published: (2025-07-01)

erbB2 Overexpression in Uterine Serous Cancer: A Molecular Target for Trastuzumab Therapy
by: Karim S. ElSahwi, et al.
Published: (2011-01-01)

In vitro synergistic effect of AXL, FAK and ErbB receptors inhibitors for head and neck cancer
by: Valeria Lucarini, et al.
Published: (2025-07-01)

ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01)

Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data
by: William W Chen, et al.
Published: (2009-01-01)

Mapping of an epitope of ErbB-2 for recognizing by monoclonal antibody 4B8 using phage display technolog
by: M. B. Borgoyakova, et al.
Published: (2016-02-01)

p53 蛋白及 c-erbB-2 蛋白在胆囊癌中的表达
Published: (1999-01-01)

Reduce Muscle Fibrosis through Exercise via NRG1/ErbB2 Modification in Diabetic Rats
by: Majid Amani, et al.
Published: (2020-01-01)

ErbB4 precludes the occurrence of PTSD-like fear responses by supporting the bimodal activity of the central amygdala
by: Kibong Sung, et al.
Published: (2024-12-01)

Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer
by: Jaekwang Jeong, et al.
Published: (2025-05-01)

The features of transcriptional activity of K-RAS gene and expression of ErbB family receptors in intestinal-type gastric adenocarcinoma
by: V. A. Tumanskiy, et al.
Published: (2017-08-01)

Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain.
by: Wei Tan, et al.
Published: (2010-09-01)

Defects in ErbB-dependent establishment of adult melanocyte stem cells reveal independent origins for embryonic and regeneration melanocytes.
by: Keith A Hultman, et al.
Published: (2009-07-01)

Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.
by: Daniel Carbajo, et al.
Published: (2015-01-01)

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
by: Axel Walch, et al.
Published: (2000-01-01)

Comparative estimation of ErbB family growth receptors, Ki-67 and E-cadherin expression in pancreatic ductal adenocarcinoma cells
by: V. A. Tumanskiy, et al.
Published: (2014-12-01)

Integrated and Functional Genomics Analysis Validates the Relevance of the Nuclear Variant ErbB380kDa in Prostate Cancer Progression.
by: Mahmoud El Maassarani, et al.
Published: (2016-01-01)

Neurotensin induces sustainable activation of the ErbB–ERK1/2 pathway, which is required for developmental competence of oocytes in mice
by: Asako Okamoto, et al.
Published: (2024-01-01)

Mesenchymal stem cell-derived exosomes improve vascular remodeling by inhibiting EGFR/ErbB2 heterodimerization in hypoxic pulmonary hypertension
by: Yao-Xin Chen, et al.
Published: (2025-07-01)

Multiple ligands simultaneous molecular docking and dynamics approach to study the synergetic inhibitory of curcumin analogs on ErbB4 tyrosine phosphorylation
by: La Ode Aman, et al.
Published: (2024-12-01)

Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation
by: Zhesong Deng, et al.
Published: (2025-05-01)

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
by: Laura M. Moser, et al.
Published: (2025-02-01)

NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB‐STAT3 signalling in a non‐m5C manner
by: Yuanbo Hu, et al.
Published: (2025-04-01)

Targeted activation of ErbB4 receptor ameliorates neuronal deficits and neuroinflammation in a food-borne polystyrene microplastic exposed mouse model
by: Chong Liu, et al.
Published: (2025-03-01)

Caracterización de cultivos neuronales de hipocampo murino como modelo de estudio de la señalización NRGs/ErbB4
by: Luis Felipe Monge-Mora, et al.
Published: (2021-12-01)

Pharmacological Activation of Rev-erbα Attenuates Doxorubicin-Induced Cardiotoxicity by PGC-1α Signaling Pathway
by: Runmei Zou, et al.
Published: (2023-01-01)

A Peptide Antagonist of the ErbB1 Receptor Inhibits Receptor Activation, Tumor Cell Growth and Migration In Vitro and Xenograft Tumor Growth In Vivo
by: Ruodan Xu, et al.
Published: (2010-01-01)

Retraction: ErbB4 preserves blood-brain barrier integrity via the YAP/PIK3CB pathway after subarachnoid haemorrhage in rats
by: Frontiers Editorial Office
Published: (2025-06-01)

Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.
by: Kevin A James, et al.
Published: (2014-01-01)

Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
by: Catrin Heim, et al.
Published: (2024-06-01)

Relationship between XRCC1 protein, miR-7, c-erbB-2 gene expression levels and radiotherapy resistance in non-small cell lung cancer
by: MA Tingting, ZHOU Liqing, SU Xinyu, XIA Jianhong, YAN Yan
Published: (2024-11-01)

Mitochondrial Amount Determines Doxorubicin‐Induced Cardiotoxicity in Cardiomyocytes
by: Weiyao Xiong, et al.
Published: (2025-03-01)

Extracellular vesicle-enriched secretome of adipose-derived stem cells upregulates clusterin to alleviate doxorubicin-induced apoptosis in cardiomyocytes
by: Wan-Tseng Hsu, et al.
Published: (2025-07-01)

Photobiomodulation Therapy Reduces Oxidative Stress and Inflammation to Alleviate the Cardiotoxic Effects of Doxorubicin in Human Stem Cell-Derived Ventricular Cardiomyocytes
by: Guilherme Rabelo Nasuk, et al.
Published: (2025-07-01)